Skip to main content
OpenTrials
Completed

NCT Number: NCT04174092

Catastrophism in Chronic Inflammatory Rheumatism

Catastrophic is defined as a negative cognitive and emotional response based on inadequate pain expression. It has three components: rumination, amplification and vulnerability. The assessment of catastrophism is carried out using a validated questionnaire called the "Pain Catatrophizing Scale" (PCS).

Recent studies highlight the significant impact of catastrophism in neuromuscular and mechanical rheumatic diseases such as gonarthrosis gonalgia and low back pain. In these diseases, it has been shown that catastrophism has a negative impact both on the experience of pain and on the response to different types of treatments (medical and surgical). Several studies have implemented multidisciplinary management and in particular cognitive-behavioural therapy with an improvement in the pain experience in patients who are catastrophic.

In chronic inflammatory rheumatic diseases such as rheumatoid arthritis, spondyloarthritis and psoriatic arthritis, the prevalence and impact of catastrophism is still poorly understood.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Inflammatory Rheumatism

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Montpellier, Montpellier, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Major patients, hospital follow-up, with RA according to ACR 2010 criteria, or spondyloarthritis according to ASAS 2009 criteria or according to AMOR or psoriatic arthritis according to Caspar 2006 criteria.
  • Patient who has given free and informed consent.
  • Patient who has signed the consent form.
  • Patient affiliated or benefiting from a health insurance plan.
  • Adult patient (≥18 years old).

Exclusion criteria

  • Patient under the protection of justice, under guardianship or curatorship.
  • Patient unable to express consent.
  • Patient for whom it is impossible to provide informed information.
  • Poor command and understanding of the French language making it impossible to complete self-questionnaires

Treatment and study plan

completing self-questionnaires

Other

completing self-questionnaires on quality of life, anxiety, insomnia, activity of rheumatic disease and catastrophism

Primary outcomes

  1. catastrophic assessment

    Time frame: Day 0

    Pain Catastrophism Scale (0= no catastrophism, 52 = maximum catastrophism)

  2. catastrophic assessment

    Time frame: at 3 months

    Pain Catastrophism Scale (0= no catastrophism, 52 = maximum catastrophism)

  3. catastrophic assessment

    Time frame: at 6 months

    Pain Catastrophism Scale (0= no catastrophism, 52 = maximum catastrophism)

  4. catastrophic assessment

    Time frame: at 12 months

    Pain Catastrophism Scale (0= no catastrophism, 52 = maximum catastrophism)

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: CRIC

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Nov 22, 2019
Registry last updated
Mar 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.